688091.SS
Price:
$66.71
Market Cap:
$13.70B
Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It develops a dosage form of paclitaxel, an anti-tumor chemotherapeutic. The company was founded in 2009 and is based in Shanghai, China.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-09-09
Stock Exchange
SHH
Ticker
688091.SS
According to Shanghai Yizhong Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.11B. This represents a change of 91.18% compared to the average of 6.86B of the last 4 quarters.
The mean historical Enterprise Value of Shanghai Yizhong Pharmaceutical Co., Ltd. over the last ten years is 5.23B. The current 13.11B Enterprise Value has changed 24.94% with respect to the historical average. Over the past ten years (40 quarters), 688091.SS's Enterprise Value was at its highest in in the March 2023 quarter at 9.02B. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.
Average
5.23B
Median
3.99B
Minimum
2.53B
Maximum
9.52B
Discovering the peaks and valleys of Shanghai Yizhong Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 97.09%
Maximum Annual Enterprise Value = 9.52B
Minimum Annual Increase = -10.79%
Minimum Annual Enterprise Value = 2.53B
Year | Enterprise Value | Change |
---|---|---|
2024 | 8.64B | -9.29% |
2023 | 9.52B | 35.74% |
2022 | 7.02B | 97.09% |
2021 | 3.56B | -10.79% |
2020 | 3.99B | 0.08% |
2019 | 3.99B | 51.45% |
2018 | 2.63B | 4.25% |
The current Enterprise Value of Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.39B
5-year avg
6.54B
10-year avg
5.23B
Shanghai Yizhong Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Zhejiang Xianju Pharmaceutical Co.,Ltd. (8.46B), less than Chengdu Kanghong Pharmaceutical Group Co., Ltd (30.44B), greater than Huapont Life Sciences Co., Ltd. (12.04B), less than Humanwell Healthcare (Group) Co.,Ltd. (41.51B), less than Kangmei Pharmaceutical Co., Ltd. (27.99B),
Company | Enterprise Value | Market cap |
---|---|---|
8.46B | $9.77B | |
30.44B | $33.87B | |
12.04B | $8.72B | |
41.51B | $36.15B | |
27.99B | $28.76B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Yizhong Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Shanghai Yizhong Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Shanghai Yizhong Pharmaceutical Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS)?
What is the 3-year average Enterprise Value for Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS)?
What is the 5-year average Enterprise Value for Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS)?
How does the current Enterprise Value for Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) compare to its historical average?